PAYX
47
5
PBI
42
-11
HBI
61
13
RCL
70
5
KHC
42
4
NTRS
39
-11
JNPR
63
5
CCI
47
-2
LOW
37
3
IRM
46
5
DE
62
2
MMM
59
3
CMI
52
11
GPC
56
5
HCA
57
2
RL
62
3
PVH
37
2
URBN
54
-2
VMC
66
6
CTAS
49
6
PAYX
47
5
PBI
42
-11
HBI
61
13
RCL
70
5
KHC
42
4
NTRS
39
-11
JNPR
63
5
CCI
47
-2
LOW
37
3
IRM
46
5
DE
62
2
MMM
59
3
CMI
52
11
GPC
56
5
HCA
57
2
RL
62
3
PVH
37
2
URBN
54
-2
VMC
66
6
CTAS
49
6
Financhill
Back

Bicara Therapeutics Vs. Strategy Industry Stock Comparison

Sell
42

BCAX
Bicara Therapeutics

Last Price:
$12.45
Seasonality Move:
--
Buy
52

MSTR
Strategy

Last Price:
$283.26
Seasonality Move:
-5.49%
Sell
42
Bicara Therapeutics (BCAX) is a Sell

Is Bicara Therapeutics a Buy, Sell or Hold?

  • The current Bicara Therapeutics [BCAX] share price is $12.44. The Score for BCAX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • BCAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Strategy (MSTR) is a Buy

Is Strategy a Buy, Sell or Hold?

  • The current Strategy [MSTR] share price is $294.27. The Score for MSTR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • MSTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

  • The Bicara Therapeutics share price today is $12.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing selling pressure, which indicates risk of future bearish movement.

MSTR Stock Price Chart

What is Strategy's stock price today?

  • The Strategy share price today is $294.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSTR is experiencing slight buying pressure.

BCAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 43.96 Sell
Chaikin Money Flow: -389508 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MSTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.38 Sell
Relative Strength Index (14 RSI): 50.53 Buy
Chaikin Money Flow: 8661825 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

BCAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.94 Sell
20-day SMA: 13.49 Sell
50-day SMA: 13.35 Sell
200-day SMA: 0 Buy
8-day EMA: 13.35 Sell
20-day EMA: 13.46 Sell
50-day EMA: 13.98 Sell
200-day EMA: 11.17 Buy

MSTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 284.75 Buy
20-day SMA: 287.61 Buy
50-day SMA: 320.37 Sell
200-day SMA: 237.74 Buy
8-day EMA: 282.26 Buy
20-day EMA: 290.16 Buy
50-day EMA: 308.43 Sell
200-day EMA: 252.4 Buy

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and a decrease next year of $0.54 per share.

Strategy Earnings Growth & MSTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $37.64 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.

Bicara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Strategy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):